Mingchen Ebitda from 2010 to 2024

002919 Stock   18.54  1.69  10.03%   
Mingchen Health's EBITDA is increasing over the years with slightly volatile fluctuation. Overall, EBITDA is expected to go to about 292.6 M this year. From 2010 to 2024 Mingchen Health EBITDA quarterly data regression line had arithmetic mean of  93,542,487 and r-squared of  0.59. View All Fundamentals
 
EBITDA  
First Reported
2016-12-31
Previous Quarter
-59.6 M
Current Value
54.7 M
Quarterly Volatility
107.5 M
 
Covid
Check Mingchen Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mingchen Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 184.1 M, Interest Expense of 3.9 M or Selling General Administrative of 18.6 M, as well as many indicators such as . Mingchen financial statements analysis is a perfect complement when working with Mingchen Health Valuation or Volatility modules.
  
This module can also supplement various Mingchen Health Technical models . Check out the analysis of Mingchen Health Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Mingchen Stock

Mingchen Health financial ratios help investors to determine whether Mingchen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mingchen with respect to the benefits of owning Mingchen Health security.